Erzsébet L.
- Country
- Hungary
- Department
- Onkológia Osztály
Research Overview
- A Phase 3, Randomized, Double-blind Study to Evaluate Perioperative Pembrolizumab (MK-3475) + Neoadjuvant Chemotherapy versus Perioperative Placebo + Neoadjuvant Chemotherapy in Cisplatin-eligible Participants with Muscle-invasive Bladder Cancer (KEYNOTE-866)
- Evaluation of Perioperative Pembrolizumab and Enfortumab Vedotin with Cystectomy Versus Cystectomy Alone in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer
Data & Insights
Has run more than one trial at 26 of 88 partner sites.
Specializations
Bladder Cancer Treatment
The investigator specializes in treating muscle-invasive bladder cancer, with particular focus on surgical and combination therapeutic approaches.
- Radical Cystectomy Procedures
- Pelvic Lymph Node Dissection
- Perioperative Treatment Strategies
Their research explores innovative treatment combinations including immunotherapy approaches for bladder cancer patients.
Surgical Oncology
The investigator focuses on surgical interventions for urological cancers, with expertise in comprehensive surgical management strategies.
- Advanced Surgical Techniques
- Perioperative Care
- Multimodal Treatment Approaches
Their work encompasses both standard and novel surgical approaches for bladder cancer treatment.
Therapeutic Innovation
The investigator evaluates combined treatment modalities including chemotherapy and immunotherapy in bladder cancer management.
- Immunotherapy Applications
- Treatment Sequencing
- Patient-Specific Approaches
Their research includes assessment of various therapeutic combinations for different patient populations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.